[Combined immunosuppressive-antiphlogistic therapy of chronic rheumatic diseases].
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002908:Chronic Disease; D003095:Collagen Diseases / Q000188:drug therapy*; D005260:Female; D006386:Hemagglutination Tests; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007841:Latex Fixation Tests; D008297:Male; D008875:Middle Aged; D014228:Triaziquone / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D014228:Triaziquone
Kombinierte immunsuppressiv-antiphlogistische Therapie bei chronisch-rheumatischen Erkrankungen.